(Q43973101)

28 November 2017

Elevated plasma levels of F2 alpha isoprostane in cystic fibrosis (English)

1 reference

28 November 2017

0 references

3

1 reference

28 November 2017

C E Collins

1

1 reference

28 November 2017

P Quaggiotto

2

1 reference

28 November 2017

E V O'Loughlin

4

1 reference

28 November 2017

R L Henry

5

1 reference

28 November 2017

M L Garg

6

1 reference

28 November 2017

1 June 1999

1 reference

28 November 2017

1 reference

28 November 2017

34

1 reference

28 November 2017

6

1 reference

28 November 2017

551-556

1 reference

https://scigraph.springernature.com/pub.10.1007/s11745-999-0397-1

28 November 2017

0 references

cites work

Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis

1 reference

12 December 2020

The isoprostanes: unique bioactive products of lipid peroxidation

1 reference

12 December 2020

The measurement and mechanism of lipid peroxidation in biological systems

1 reference

12 December 2020

Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors

1 reference

12 December 2020

The measurement of free radical reactions in humans. Some thoughts for future experimentation

1 reference

12 December 2020

Current knowledge on fatty acids in cystic fibrosis

1 reference

12 December 2020

Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n−3 polyunsaturated fatty acids: study design implications

1 reference

12 December 2020

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

12 December 2020

Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage

1 reference

12 December 2020

Correction of linoleic acid deficiency in cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis, breath pentane, and lipid peroxidation

1 reference

12 December 2020

Fat gram target to achieve high energy intake in cystic fibrosis

1 reference

12 December 2020

Stimulatory effect of 8-Epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release

1 reference

12 December 2020

8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo

1 reference

12 December 2020

Oxidative stress in cystic fibrosis: does it occur and does it matter?

1 reference

12 December 2020

Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis

1 reference

12 December 2020

Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients

1 reference

12 December 2020

Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.

1 reference

12 December 2020

Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis

1 reference

12 December 2020

Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis

1 reference

12 December 2020

Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation

1 reference

12 December 2020

Isolation of human erythrocyte membranes in glucose solution

1 reference

12 December 2020

Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study

1 reference

12 December 2020

Carotenoid levels in normal children and in children with cystic fibrosis

1 reference

12 December 2020

Direct transesterification of all classes of lipids in a one-step reaction

1 reference

12 December 2020

The isoprostanes. Current knowledge and directions for future research

1 reference

12 December 2020

Selenium and oxidant injury in patients with cystic fibrosis

1 reference

12 December 2020

Selenium (Se) status and antioxidant injury in cystic fibrosis (CF) children.

1 reference

12 December 2020

Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease

1 reference

12 December 2020

Is pentane a normal constituent of human breath?

1 reference

12 December 2020

Role of nonenzymatically generated prostanoid, 8-iso-PGF2 alpha, in pulmonary oxygen toxicity

1 reference

12 December 2020

10.1007/S11745-999-0397-1

Identifiers

DOI

1 reference

28 November 2017

1 reference